Carisma Therapeutics Inc. Annual Operating Lease, Payments in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Carisma Therapeutics Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2018 to 2024.
  • Carisma Therapeutics Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.46M, a 1.04% increase year-over-year.
  • Carisma Therapeutics Inc. annual Operating Lease, Payments for 2024 was $5.81M, a 0.75% increase from 2023.
  • Carisma Therapeutics Inc. annual Operating Lease, Payments for 2023 was $5.76M, a 21.3% increase from 2022.
  • Carisma Therapeutics Inc. annual Operating Lease, Payments for 2022 was $4.75M.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $5.81M +$43K +0.75% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $5.76M +$1.01M +21.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $4.75M +$4.75M Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2022-02-28
2020 $0 -$236K -100% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $236K +$236K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.